Kim Ju-Yeon, Jung Eun Jung, Park Taejin, Jeong Sang-Ho, Jeong Chi-Young, Ju Young-Tae, Lee Young-Joon, Hong Soon-Chan, Ha Woo-Song, Choi Sang-Kyung
Department of Surgery, School of Medicine, Gyeongsang National University, Jin-ju, South Korea.
Department of Surgery, School of Medicine, Gyeongsang National University, Jin-ju, South Korea
Jpn J Clin Oncol. 2015 May;45(5):411-5. doi: 10.1093/jjco/hyv018. Epub 2015 Feb 10.
We investigated the prognostic importance of pre-operative Breast Imaging Reporting and Data System classification in ultrasound imaging.
Histopathological differences and disease-free survival were analyzed in Breast Imaging Reporting and Data System classification subgroups. Univariate and multivariate analyses were used to identify the prognostic factors.
We identified 531 invasive breast cancer patients eligible for this study. Most patients classified as Breast Imaging Reporting and Data System 5 had large tumors and a higher rate of lymph node metastasis. However, hormonal receptor or HER-2 status did not differ according to Breast Imaging Reporting and Data System classification. During a median post-operative follow-up of 42.0 months, 43 patients were diagnosed with a disease-specific event. Disease-free survival was significantly lower in patients with Breast Imaging Reporting and Data System 5 than in patients with Breast Imaging Reporting and Data System 3-4. Subgroup analysis of patients with invasive breast cancer of Stage I showed that Breast Imaging Reporting and Data System 5 was an independent negative prognostic indicator of disease-free survival (hazard ratio 9.195; 95% confidence interval, 1.175-71.955; P = 0.035).
Breast Imaging Reporting and Data System classification might be considered as prognostic factors especially in Stage I breast cancer. Further confirmatory studies are needed.
我们研究了术前乳腺影像报告和数据系统(Breast Imaging Reporting and Data System,BI-RADS)超声分类的预后重要性。
对BI-RADS分类亚组的组织病理学差异和无病生存率进行分析。采用单因素和多因素分析来确定预后因素。
我们确定了531例符合本研究条件的浸润性乳腺癌患者。大多数分类为BI-RADS 5类的患者肿瘤较大且淋巴结转移率较高。然而,激素受体或HER-2状态根据BI-RADS分类并无差异。在术后中位随访42.0个月期间,43例患者被诊断为疾病特异性事件。BI-RADS 5类患者的无病生存率显著低于BI-RADS 3-4类患者。对I期浸润性乳腺癌患者的亚组分析表明,BI-RADS 5类是无病生存率的独立阴性预后指标(风险比9.195;95%置信区间,1.175-71.955;P = 0.035)。
BI-RADS分类可被视为预后因素,尤其是在I期乳腺癌中。需要进一步的验证性研究。